Hospital
Grinnell Regional Medical Center
Grinnell Regional Medical Center was paid $2.22M by Medicaid between Jan 2018 and Dec 2024, across 70 billing codes. Its largest line is 99284, emergency room visit (serious) — 40% of everything it billed.
33Billing provider infoGRINNELL REGIONAL MEDICAL CENTER
GRINNELL, IA 50112
GRINNELL, IA 50112
33aNPI1669420501assigned 05/04/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$2.22M
24GClaims50,436
24DCodes billed70
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Iowa
Rank by total paid#19 of 29
Median peer was paid$6.37M
This provider vs. median0.3×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 7,296 | $413K | |
| 2019 | 7,612 | $413K | |
| 2020 | 6,872 | $333K | |
| 2021 | 7,302 | $363K | |
| 2022 | 10,031 | $424K | |
| 2023 | 7,810 | $211K | |
| 2024incomplete | 3,513 | $66K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 40% | 4,613 | 3,801 | $883K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 32% | 6,239 | 4,448 | $720K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 5.5% | 460 | 401 | $122K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 5.3% | 8,601 | 8,142 | $118K |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 3.1% | 219 | 212 | $69K |
| 96361 | Intravenous infusion, hydration; each additional hour | 1.7% | 457 | 423 | $38K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 1.4% | 218 | 206 | $32K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 1.3% | 358 | 351 | $30K |
| 36415 | Collection of venous blood by venipuncture | 1.1% | 6,843 | 6,136 | $26K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 1.1% | 1,066 | 1,050 | $25K |
| 80053 | Comprehensive metabolic panel | <1% | 3,940 | 3,716 | $14K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 951 | 917 | $13K |
58 more codes
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 6,031 | $12K |
| 84425 | <1% | 671 | $11K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 290 | $11K |
| 83970 | <1% | 307 | $10K | |
| 82607 | <1% | 839 | $10K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 16 | $10K |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 371 | $10K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 102 | $6K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 67 | $4K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 119 | $4K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 484 | $4K |
| 87428 | <1% | 143 | $4K | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 176 | $4K |
| 84255 | <1% | 154 | $3K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 105 | $3K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 181 | $2K |
| 84597 | <1% | 197 | $2K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 95 | $2K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 70 | $2K |
| 82746 | <1% | 141 | $2K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 33 | $2K |
| 84590 | <1% | 172 | $2K | |
| 84446 | <1% | 138 | $2K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 50 | $1K |
| 83540 | <1% | 293 | $1K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 50 | $1K |
| 80061 | Lipid panel | <1% | 120 | $1K |
| 82525 | <1% | 108 | $1K | |
| 84630 | <1% | 105 | $929.51 | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 15 | $905.52 |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 149 | $818.59 |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 122 | $579.38 |
| 84439 | <1% | 59 | $325.66 | |
| 76000 | <1% | 13 | $257.62 | |
| 86780 | <1% | 24 | $226.44 | |
| 81002 | <1% | 54 | $159.89 | |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 13 | $102.40 |
| 83550 | <1% | 13 | $77.26 | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 29 | $76.58 |
| 83690 | <1% | 600 | $60.99 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 303 | $38.39 |
| 81001 | <1% | 992 | $30.05 | |
| 81025 | <1% | 45 | $16.36 | |
| 83735 | <1% | 165 | $6.50 | |
| 81003 | <1% | 43 | $2.14 | |
| A9270 | Non-covered item or service | 0% | 475 | $0.00 |
| J2704 | Injection, propofol, 10 mg | 0% | 469 | $0.00 |
| 80048 | Basic metabolic panel (calcium, ionized) | 0% | 129 | $0.00 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 0% | 82 | $0.00 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 0% | 91 | $0.00 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 0% | 27 | $0.00 |
| 82150 | 0% | 64 | $0.00 | |
| 84484 | 0% | 18 | $0.00 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 0% | 121 | $0.00 |
| 0353U | 0% | 31 | $0.00 | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 0% | 117 | $0.00 |
| J7120 | Ringers lactate infusion, up to 1000 cc | 0% | 565 | $0.00 |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 0% | 15 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialCAVAZOS, DAVID-PAUL (RURAL PRESIDENT)
| Provider | Location | Paid |
|---|---|---|
| Grinnell Regional Medical Center | Grinnell, IA | $5.60M |
| Grinnell Regional Medical Center | Grinnell, IA | $865K |
| Grinnell Regional Medical Center | Montezuma, IA | $152K |
| Grinnell Regional Medical Center | Grinnell, IA | $55K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.